About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,045 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,045 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6441-6460 of 8,045 trials

Unknown99mTc-H7ND SPECT/CT Imaging in NSCLCTo study the clinical application of 99mTc-H7ND SPECT/CT imaging in the efficacy evaluation and prediction of non-small cell lung cancer (NSCLC)NCT05999214·Xi'an, Shaanxi Active not recruitingA Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsA study evaluating the safety, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of ABBV-927 with ABBV-368, Budigalimab (ABBV-181) and/or chemotherapy in…NCT03893955·Springdale, Arkansas and 25 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

TerminatedDose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLCThe purpose of this study is to understand the effects (good and/or bad) of the addition of RAD001 to standard radiation and chemotherapy (cisplatin and pemetrexed) for patients…NCT01063478·Chicago, Illinois

CompletedA Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular CarcinomaThe main purpose of this study is to evaluate the safety, tolerability, and efficacy of the study drug known as galunisertib in combination with nivolumab in participants with…NCT02423343·Birmingham, Alabama and 8 others

TerminatedTislelizumab Combined With Sitravatinib as Consolidation Treatment Following Concurrent Chemoradiation in Patients With Locally Advanced, Unresectable NSCLCThis study aims to evaluate the 1-year progression free survival (PFS) rate of tislelizumab combined with sitravatinib as assessed by investigators per RECIST 1.1.NCT05176925·Shanghai

RecruitingA Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior ChemotherapyARCH is a randomised, stratified, multicentre, phase III trial.NCT06931717·Vienna and 34 others

UnknownConcurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLCThe standard treatment for patients with Non-Small Cell Lung Cancer (NSCLC) and clinically negative lymph nodes remains surgery per current guidelines.NCT02619448·Syracuse, New York

CompletedSintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLCEfficacy and Safety Evaluation of IBI308 in Patients with Advanced or Recurrent Squamous NSCLCNCT03629925·Shanghai, Shanghai Municipality

RecruitingMechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung CancerThis is an exploratory clinical study focusing on the neoadjuvant treatment of non-small cell lung cancer (NSCLC).NCT07359040·Beijing, Beijing Municipality

TerminatedCustomizing First Line Chemotherapy in Advanced Non-Small Cell Lung CancerThe study aims at piloting the concept of customization of chemotherapy based on molecular markers in patients with stage IIIB (with pleural effusion) and IV with performance…NCT01356368·Riyadh

Active not recruitingA Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic AlterationsThis study will compare Valemetostat Tosylate Plus Pembrolizumab vs Pembrolizumab Alone in First-line NSCLC Without Actionable Genomic AlterationsNCT06644768·La Jolla, California and 34 others

UnknownProphylactic Cranial Irradiation Versus Observation in Stage IV NSCLC Randomized Controlled Clinical StudyLung cancer has remained the leading cause of cancer-related deaths worldwide.NCT06014450·Guiyang, Guizhou

CompletedCarboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)This is a phase II study in previously untreated subjects with histologically or cytologically proven stage IIIB/IV NSCLC designed to determine the efficacy of first line…NCT00097214·Bentonville, Arkansas and 7 others

Not yet recruitingDocetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)This is a global, multicenter, randomized, double-blind, placebo-controlled Phase 3 study evaluating docetaxel plus plinabulin versus docetaxel plus placebo in participants with…NCT07361484

CompletedMolecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung CancerThe purpose of this study is to develop an ultra sensitive assay of mutation detection on circulating tumor DNA (ctDNA) for treatment, diagnosis and monitoring disease progression…NCT02169349·Rennes

RecruitingA Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)Genes give your body instructions on how to make proteins. Proteins are needed to keep the body working properly.NCT07140016·Fullerton, California and 16 others

CompletedVaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced TumorsRATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Colony-stimulating factors such as sargramostim may increase the number of immune cells.NCT00003125·Washington D.C., District of Columbia and 1 other

TerminatedFocused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid TumorsThis study evaluates whether it is safe to Focused Ultrasound Ablation (FUSA) treatments with and without PD-1 blockade and with and without intratumoral poly-ICLC.NCT04116320·Charlottesville, Virginia

CompletedTrial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung CancerThe purpose of this study is to evaluate the safety of the combination of ponatinib and trametinib as well as the most appropriate dosages of the combination.NCT03704688·Basking Ridge, New Jersey and 6 others

TerminatedTrial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung CancerThis study is a single institution Phase II single arm trial to assess the efficacy of the combination of pevonedistat plus docetaxel in patients with previously treated advanced…NCT03228186·Ann Arbor, Michigan

PreviousPage 323 of 403Next